MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Therapeutic Effects of Cannabinoids Pain Relief: Perhaps one of the most recognized therapeutic effects of cannabinoids is pain relief.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research. Clinical Trial Sample Size.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Most of the data came from five states that list these indications as qualifying conditions for the use of medical cannabis. The Upshot.

Data 105

Data Clinical Trials Research and Development Indica 105

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Doctors prescribe various forms of opiods to cancer patients for pain. Spain researches advanced use of cannabis medications.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

JUNE 8, 2021

OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the University of California San Francisco (UCSF). Englewood Cliffs, NJ, June 08, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Doctors prescribe various forms of opiods to cancer patients for pain. Spain researches advanced use of cannabis medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

AUGUST 26, 2022

Several companies are facilitating the development of this product. More research is still needed to explore this uncharted territory. However, deeper research is needed to better understand its roles. Apart from this, various clinical trials are done for multiple conditions. billion by the year 2028.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

The Cannigma

MAY 1, 2023

Previously thought of as either a horse tranquilizer or a dissociative recreational party drug, ketamine has re-emerged as a promising therapeutic agent to treat pain, PTSD, depression, anxiety and more. This effect of opioids increasing the perception of pain is called opioid-induced hyperalgesia.

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Cannabis Law Report

SEPTEMBER 22, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. A vast majority of CBD developers are pursuing compounds targeted to CB2 that have minimal CB1 affinity.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., Moreover, the FDA has also allowed researchers to conduct CBD trials. So, there are huge developments after that. after its consumption.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

SpeedWeed

AUGUST 4, 2021

After watching my brother self-medicate for his chronic pain for decades, I didn’t understand how cannabis was important to him as a medicine. I always thought he used his chronic pain as an “excuse” to self-administer what I thought was a toxic drug. . in 2014, I watched my brother walk into a cannabis clinic.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Chronic pain. Chronic pain. Do not offer the following to manage chronic pain in adults: nabilone. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. the person’s clinical condition is stable.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

CannaTech

MARCH 24, 2019

Medical cannabis is making its way out of the haze and into the headlines as expanded research programs demonstrate its proven benefits. Some of the most recognized applications of cannabinoid-based medicine are in the treatment of neuropathic pain , inflammation and muscle spasticity. However, this is slowly changing.

Research and Development 45

Research and Development Therapy Clinical Trials Chronic Pain 45

Cannabis Law Report

JULY 9, 2021

Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. In June 2021, similar measures were passed in Connecticut and Texas, where medical research on psilocybin is now also legal on a statewide level.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

OCTOBER 26, 2021

MyMD’s lead drug candidate, MYMD-1, is being developed to target aging and related diseases along with autoimmune diseases including rheumatoid arthritis. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Dr. Chapman Bio.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

NOVEMBER 16, 2021

As cleared by the FDA, the primary endpoint of the Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the circulating levels of tumor necrosis factor-alpha (TNF-?), MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-? About MYMD-1.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

JUNE 24, 2021

While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. By interacting with the receptors of the ECS, cannabis modulates the bodily functions that cause or exacerbate health conditions.

CBD 75

CBD Microdosing Edibles Sleep 75

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 9, 2022

The bill aims to improve the quality of medical services for the population that undergoes palliative medicine and encourage medical research on cannabis.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

APRIL 10, 2019

In November, UK law changed to allow clinicians to prescribe medical cannabis under limited conditions. The Government need to push for centres of excellence to help to stimulate the research they say they are calling for.”. To date, research has centred on two major cannabinoids, tetrahydrocannabinol and cannabidiol.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1: Bionorica SE BX-1 is an oral solution containing dronabinol, being developed by Bionorica.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1 is an oral solution containing dronabinol, being developed by Bionorica. BX-1: Bionorica SE.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). major depressive disorder, post-traumatic stress disorder, acute suicidality).

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Key findings from the pre-clinical trial are as follows: SCI-160 significantly alleviates pain up to 6 hours after injection as compared with vehicle-treated animals. TEL AVIV, Israel , Aug. after injection.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

CannaMD

NOVEMBER 8, 2019

VA scientists may conduct research on marijuana benefits and risks, and potential for abuse, under regulatory approval. Research suggests that marijuana may work in a number of different ways to decrease PTSD symptoms. VA pharmacies may not fill prescriptions for medical marijuana. You’re Not Alone.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). major depressive disorder, post-traumatic stress disorder, acute suicidality).

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 108

Programs Research and Development Education Treatment 108

The Cannigma

MARCH 12, 2021

However, many customers, new medical cannabis customers are going into the dispensary with a note from their doctor saying you qualify under one of the state conditions that enable you to use cannabis. I think when customers go to a dispensary, they’re assuming it’s going to be the same type of experience. How do you address that?

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. The precis is simple. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 40

Programs Research and Development Education Treatment 40

Green Relief

MAY 13, 2018

Preclinical research and anecdotal accounts indicate that CBD is highly active against brain ischemia, modulating many of the molecular hallmarks of TBI pathology. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. The patent.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis.

Banking 45

Banking Research and Development Legislation Programs 45